ImmuCell Reports Q3 Sales Up 46% to $8.0 Million

Preliminary, unaudited third-quarter sales were $8.0 million, up 46.0% year over year. Domestic sales rose 29.2% to $6.9 million; nine-month sales increased 27.8% to $25.6 million.